Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Comparison of clinical features among Parkinson's disease subtypes: A large retrospective study in a single center.

Konno T, Deutschländer A, Heckman MG, Ossi M, Vargas ER, Strongosky AJ, van Gerpen JA, Uitti RJ, Ross OA, Wszolek ZK.

J Neurol Sci. 2018 Mar 15;386:39-45. doi: 10.1016/j.jns.2018.01.013. Epub 2018 Jan 11.

PMID:
29406964
2.

VPS35-Related Parkinson Disease.

Deutschländer A, Ross OA, Wszolek ZK.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2017 Aug 10.

3.

Mitochondrial membrane protein-associated neurodegeneration.

Deutschländer A, Konno T, Ross OA.

Parkinsonism Relat Disord. 2017 Jun;39:1-3. doi: 10.1016/j.parkreldis.2017.03.014. Epub 2017 Mar 21. No abstract available.

PMID:
28359667
4.

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients.

Deutschländer A, la Fougère C, Boetzel K, Albert NL, Gildehaus FJ, Bartenstein P, Xiong G, Cumming P.

Neuroimage Clin. 2016 Jun 9;12:41-6. doi: 10.1016/j.nicl.2016.06.007. eCollection 2016.

5.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium.

Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

6.

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.

Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschländer A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Van Broeckhoven C; GEO-PD Consortium.

Neurology. 2014 Nov 18;83(21):1906-13. doi: 10.1212/WNL.0000000000001012. Epub 2014 Oct 17.

7.

Cerebellar and visual gray matter brain volume increases in congenital nystagmus.

Hüfner K, Stephan T, Flanagin VL, Deutschländer A, Dera T, Karch C, Linn J, Glasauer S, Dieterich M, Strupp M, Brandt T.

Front Neurol. 2011 Sep 29;2:60. doi: 10.3389/fneur.2011.00060. eCollection 2011.

8.

Differential effects of eyes open or closed in darkness on brain activation patterns in blind subjects.

Hüfner K, Stephan T, Flanagin VL, Deutschländer A, Stein A, Kalla R, Dera T, Fesl G, Jahn K, Strupp M, Brandt T.

Neurosci Lett. 2009 Nov 27;466(1):30-4. doi: 10.1016/j.neulet.2009.09.010. Epub 2009 Sep 18.

PMID:
19766168
9.

Vestibular cortex activation during locomotor imagery in the blind.

Deutschländer A, Stephan T, Hüfner K, Wagner J, Wiesmann M, Strupp M, Brandt T, Jahn K.

Ann N Y Acad Sci. 2009 May;1164:350-2. doi: 10.1111/j.1749-6632.2009.03863.x.

PMID:
19645926
10.

Human hippocampal activation during stance and locomotion: fMRI study on healthy, blind, and vestibular-loss subjects.

Jahn K, Wagner J, Deutschländer A, Kalla R, Hüfner K, Stephan T, Strupp M, Brandt T.

Ann N Y Acad Sci. 2009 May;1164:229-35. doi: 10.1111/j.1749-6632.2009.03770.x.

PMID:
19645904
11.

Imagined locomotion in the blind: an fMRI study.

Deutschländer A, Stephan T, Hüfner K, Wagner J, Wiesmann M, Strupp M, Brandt T, Jahn K.

Neuroimage. 2009 Mar 1;45(1):122-8. doi: 10.1016/j.neuroimage.2008.11.029. Epub 2008 Dec 6.

PMID:
19100840
12.

Supraspinal locomotor control in quadrupeds and humans.

Jahn K, Deutschländer A, Stephan T, Kalla R, Hüfner K, Wagner J, Strupp M, Brandt T.

Prog Brain Res. 2008;171:353-62. doi: 10.1016/S0079-6123(08)00652-3.

PMID:
18718326
13.

Nicotine-induced nystagmus correlates with midpontine activation.

Deutschländer A, Stephan T, Riedel E, Zingler VC, Hüfner K, Wiesmann M, Pierrot-Deseilligny C, Strupp M, Brandt T.

Neuroimage. 2008 Jun;41(2):479-82. doi: 10.1016/j.neuroimage.2008.03.001. Epub 2008 Mar 12.

PMID:
18417364
14.

Unilateral vestibular failure suppresses cortical visual motion processing.

Deutschländer A, Hüfner K, Kalla R, Stephan T, Dera T, Glasauer S, Wiesmann M, Strupp M, Brandt T.

Brain. 2008 Apr;131(Pt 4):1025-34. doi: 10.1093/brain/awn035. Epub 2008 Mar 5.

PMID:
18321924
15.

Differences in saccade-evoked brain activation patterns with eyes open or eyes closed in complete darkness.

Hüfner K, Stephan T, Glasauer S, Kalla R, Riedel E, Deutschländer A, Dera T, Wiesmann M, Strupp M, Brandt T.

Exp Brain Res. 2008 Apr;186(3):419-30. doi: 10.1007/s00221-007-1247-y. Epub 2008 Jan 9.

PMID:
18183378
16.

Imaging human supraspinal locomotor centers in brainstem and cerebellum.

Jahn K, Deutschländer A, Stephan T, Kalla R, Wiesmann M, Strupp M, Brandt T.

Neuroimage. 2008 Jan 15;39(2):786-92. Epub 2007 Oct 10.

PMID:
18029199
17.

Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus.

Hüfner K, Stephan T, Kalla R, Deutschländer A, Wagner J, Holtmannspötter M, Schulte-Altedorneburg G, Strupp M, Brandt T, Glasauer S.

Neurology. 2007 Sep 11;69(11):1128-35.

PMID:
17846412
18.

Pulse-synchronous rotational and vertical pendular eye movements in superior canal dehiscence syndrome.

Deutschländer A, Jahn K, Strupp M, Brandt T.

Eur J Neurol. 2007 Jan;14(1):e29. No abstract available.

PMID:
17222087
19.

A randomized trial of deep-brain stimulation for Parkinson's disease.

Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group, Neurostimulation Section.

N Engl J Med. 2006 Aug 31;355(9):896-908. Erratum in: N Engl J Med. 2006 Sep 21;355(12):1289.

20.

Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.

Deutschländer A, Asmus F, Marelli E, Klopstock T, Gasser T, Bötzel K.

Mov Disord. 2006 Sep;21(9):1523-5.

PMID:
16755578

Supplemental Content

Loading ...
Support Center